Luteinizing hormone-releasing hormone antagonists in prostate cancer.
about
Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice.Controversies surrounding androgen deprivation for prostate cancer.Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.Management of prostate cancer. Part 3: metastatic disease.Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist.Metabolic stability of long-acting luteinizing hormone-releasing hormone antagonists.
P2860
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@en
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@nl
type
label
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@en
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@nl
prefLabel
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@en
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@nl
P1433
P1476
Luteinizing hormone-releasing hormone antagonists in prostate cancer.
@en
P2093
H J Stricker
P356
10.1016/S0090-4295(01)01238-9
P407
P433
P577
2001-08-01T00:00:00Z